Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Millions of dollars a day for the last month has been coming into the stock. This beast is about to get beastly.
Epic stock of 2022
I think those numbers will be in the rear view mirror
I smell an epic run in the making
Go INND
INND looks like very heavy accumulation. This could be the epic run of 2022.
You’ll notice even on volatile days it appears people are not selling the rips but continue to buy the dips.
I think we are close to a monumental run.
I believe your statement is correct.
This would explain why such heavy bashing going on. If crown bridge notes get cancelled , over 10 percent of the companies outstanding disappear and possibly need to be repurchased in the open market. Dragon lady ? Thoughts ?
Huge news for INND and it’s shareholders.
Read the following recent litigation release with crown bridge .
https://www.sec.gov/litigation/litreleases/2022/lr25461.htm
Then read the recent record INND quarter and their note holders. Page 6 specifically. With crown bridge.
https://www.otcmarkets.com/otcapi/company/financial-report/342247/content
This fund had almost a billion shares in INND that looks to have been sanctioned by the SEC 2 weeks ago. It’s very possible these are the share cancellations for INND and if they sold them into the market , they may need to be repurchased.
Over 10 percent of the company may be cancelled and possibly those 700 plus million shares may need to be re bought in the market.
The stock of 2022 may become even more epic.
Around 4.6 billion, they also had no business and the potential merger wasn’t as big as INND.
INND has them beat in all respects. Since TSNP went from .0001 to dollars, could it happen here ??
ALPP was another TSNP. Only bigger. Maybe INND follows . . . .
My guess is a lot. But we will see shortly !! It will be the longest 20 days of an investors life ! ??
INND Upcoming massive share cancellation could be the final catalyst needed to break this companies share price out to the stratosphere. The run could be epic.
Stock of 2022
Go INND
For value investors , one of the biggest catalysts to understand is that INND manufactures their own product.
FDA NEWS RELEASE
FDA Finalizes Historic Rule Enabling Access to Over-the-Counter Hearing Aids for Millions of Americans
More Affordable Hearing Aids Could Be in Stores as Soon as Mid-October
Share
Tweet
Email
For Immediate Release:
August 16, 2022
Español
Today, the U.S. Food and Drug Administration issued a final rule to improve access to hearing aids which may in turn lower costs for millions of Americans. This action establishes a new category of over-the-counter (OTC) hearing aids, enabling consumers with perceived mild to moderate hearing impairment to purchase hearing aids directly from stores or online retailers without the need for a medical exam, prescription or a fitting adjustment by an audiologist.
The rule is expected to lower the cost of hearings aids, furthering the Biden-Harris Administration’s goal of expanding access to high-quality health care and lowering health care costs for the American public. It is designed to assure the safety and effectiveness of OTC hearing aids, while fostering innovation and competition in the hearing aid technology marketplace.
Today’s action follows President Biden's Executive Order on Promoting Competition in the American Economy, which called for the FDA to take steps to allow hearing aids to be sold over the counter and set a swift 120-day deadline for action, which the FDA met. In 2017, Congress passed bipartisan legislation requiring the FDA to create a category of OTC hearing aids, but it was not fully implemented until now. Consumers could see OTC hearing aids available in traditional retail and drug stores as soon as mid-October when the rule takes effect.
“Reducing health care costs in America has been a priority of mine since Day One and this rule is expected to help us achieve quality, affordable health care access for millions of Americans in need,” said Health and Human Services Secretary Xavier Becerra. “Today’s action by the FDA represents a significant milestone in making hearing aids more cost-effective and accessible.”
Close to 30 million adults in the U.S. could benefit from hearing aid use. Individuals with permanent hearing impairment can use hearing aids to help make speech and sounds louder, improving the ability to communicate effectively with others. Many hearing aids can be expensive. The final rule aims to stimulate competition and facilitate the sale of safe and effective OTC hearing aids in traditional retail stores or online nationwide, providing consumers with perceived mild to moderate hearing loss with improved access to devices that meet their needs and are less expensive than current options.
“Hearing loss is a critical public health issue that affects the ability of millions of Americans to effectively communicate in their daily social interactions,” said FDA Commissioner Robert M. Califf, M.D. “Establishing this new regulatory category will allow people with perceived mild to moderate hearing loss to have convenient access to an array of safe, effective and affordable hearing aids from their neighborhood store or online.”
The OTC category established in this final rule applies to certain air-conduction hearing aids intended for people 18 years of age and older who have perceived mild to moderate hearing impairment. Hearing aids that do not meet the requirements for the OTC category (for example, because they are intended for severe hearing impairment or users younger than age 18) are prescription devices.
The FDA finalized the rule after receiving and reviewing more than 1,000 public comments on the proposed rule issued on Oct. 20, 2021. Comments submitted by consumers, professional associations, hearing aid manufacturers, public health organizations and advocacy groups, members of Congress, state agencies, and other stakeholders are summarized in the final rule, along with the FDA’s respective responses. In response to public comments and to assure the safety and effectiveness of OTC hearing aids, the final rule incorporates several changes from the proposed rule, including lowering the maximum sound output to reduce the risk to hearing from over-amplification of sound, revising the insertion depth limit in the ear canal, requiring that all OTC hearing aids have a user-adjustable volume control, and simplifying the phrasing throughout the required device labeling to ensure it is easily understood. The final rule also includes performance specifications and device design requirements specific to OTC hearing aids.
Furthermore, today’s action correspondingly amends existing rules that apply to prescription hearing aids for consistency with the new OTC category, it repeals the conditions for sale for hearing aids, and it includes provisions that address some of the effects of the FDA OTC hearing aid regulations on state regulation of hearing aids.
Concurrently with issuing the final rule, the FDA also issued the final guidance, Regulatory Requirements for Hearing Aid Devices and Personal Sound Amplification Products (PSAPs), to clarify the differences between hearing aids, which are medical devices, and PSAPs, consumer products that help people with normal hearing amplify sounds.
The effective date for the final rule is 60 days following publication in the Federal Register. Manufacturers of hearing aids sold prior to the effective date of the final rule will have 240 days after its publication to comply with the new or revised requirements. For hearing aids that have not been offered for sale prior to the effective date, compliance with the new or revised requirements must be achieved before marketing the device, including obtaining 510(k) clearance if applicable.
https://www.fda.gov/news-events/press-announcements/fda-finalizes-historic-rule-enabling-access-over-counter-hearing-aids-millions-americans
Inner scope, in my opinion ,has to be the best hearing aid opportunity out their. Some other hearing aid companies are running, but while they were downsizing during the uncertain 7 year rule change , INND was preparing for a favorable ruling. And it is going to be paying off huge now. They positioned thousands of stores with product and literature and promotions over the last few years and now the otc rule is favorable and INND is in the best possible place.
The strategic business move paid off big.
INND right place right time
50 and 200 crossed with strength. Now we could see what size run could happen !!
Go INND
Tsnp ran from .0001 into many dollars. With more shares and not even close the business.
INND has more catalysts and cash flows.
INND meme mania looks to be starting soon.
Still very early to the game !
Go INND !
If we break the 2.5 cent left side of the cup and handle formation , it could trigger a big run.
If we break the 9 cent larger 2 year cup and handle formation , the run could be epic
Good news: The FDA has issued a new rule to allow hearing aids to be sold over the counter. pic.twitter.com/3WJLUueEwt
— Vice President Kamala Harris (@VP) August 16, 2022
The damn is breaking !!
Looks like the big gap days are about to start. No shares left and people are starting to see the gold mine of a stock this is.
When INND starts to do PR it should really explode then.
Go INND
Premarket gap to 50 cents ?? ??. Amazing ! 6 million in quarterly revs with 3 million net. Show me any penny stock with those types of numbers.
Ceo Moore made reference to a hockey stick growth pattern. He delivered.
I am amazed the stock has not caught fire and gapped significantly higher yet.
Fridays are notoriously slow, maybe still some bargain prices tomorrow.
I don’t think it can stay this low for too much longer. The cat is getting out of the bag.
INND. Stock of 2022
The skies are getting very blue . .
Golden, are you able to post a 200 and 50 day chart ?
INND
The damns about to break
When the 50 and 200 moving averages collide . . . . Watch out above
Looks like an epic move about to happen. Blue skies ahead
INND
INND is also the same company that did 400,000 in revs last quarter. Which means they are currently experiencing exponential growth. It’s also called emerging growth.
Investors value things many months to even years in advance and that is currently what’s happening. As more and more people find out about this soon to be potential 9 figure company , they are making valuation bets on what the stock price should be.
Personally , I think it should be many many many many times higher.
Over 7 dollars.
Alpp did the same.
What will INND do ????
TSNP went from .0001 to 7 dollars within 6 months and had more shares out and way less projected business.
INND is in much better and bigger shape with a lot more more catalysts.
FDA ruling concluded. Cautiously optimistic after 7 years in the works.
INND worked on placement during the ruling adjudication period the whole time. If the ruling is favorable , INND will be in the best place possible. Stock of 2022
Listen to this interview from Friday.
OTCMKTS: $INND
— Benzinga (@Benzinga) August 5, 2022
Check out our latest interview with Matthew Moore, President, Co-Founder, and CEO, InnerScope Hearing Technologies, Inc.
Follow them here! @inndstockhttps://t.co/a5vuLwBioi#audiotech #healthcare #digitalhealth #retail#ad pic.twitter.com/NwkLOEAvdk
FDA ruling deemed “economically significant”
INND shareholders should see an amplification of that statement.
Big big stuff coming
As real as it gets. It hasn’t even started yet. Welcome to the ground floor
Could be breakout hour coming.
Rite aid , Inner scope INND distribution deal might finally be getting out. Volume is picking up.
I am amazed it’s still trading so low. The Penny stocks best kept secret.
If it breaks .0132 with any strength it could run
The 50 and 200 day moving average are close to touching. The stock could gap and run huge soon.
It’s a good sign that it’s clean and can move
Summer stock 2022
Epic run
Innd is about cash flow positive, we are waiting for the filings. Also they are positioning distributors and should be first to market upon a potential fda approval.
But inventory can be purchased before hand , which I believe is why Matt said INND has a 6 month backlog.
You’ll notice at the cardinal conference he expects 2 million in recurring monthly orders.
Summer stock 2022. Paper coming